Guardian Investor Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Guardian Investor Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$196K	Hold	1,664	–	–	0.16%	163
2014 Q4	$198K	Sell	1,664 -24	-1%	-$2.7K	0.16%	157
2014 Q3	$190K	Sell	1,688 -66	-4%	-$6.28K	0.15%	159
2014 Q2	$166K	Sell	1,754 -49	-3%	-$3.44K	0.13%	195
2014 Q1	$128K	Sell	1,803 -62	-3%	-$4.91K	0.1%	244
2013 Q4	$139K	Buy	+1,865	New	+$130K	0.11%	220

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Guardian Investor Services's VRTX Position: Q1 2015 in Review

Guardian Investor Services held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2015 at 1,664 shares worth $196K. The position accounts for 0.16% of the portfolio, ranked #163.

Guardian Investor Services first reported a position in VRTX in Q4 2013 and has held it in 6 quarters since. The position peaked at $198K in Q4 2014. 480 funds tracked by Wall St. Rank hold VRTX as of Q1 2015.

Guardian Investor Services held 1,664 shares of Vertex Pharmaceuticals worth $196K as of Q1 2015.
Guardian Investor Services left its Vertex Pharmaceuticals share count unchanged in Q1 2015.
Vertex Pharmaceuticals made up 0.16% of Guardian Investor Services's portfolio in Q1 2015, its #163 holding.
Guardian Investor Services first reported a position in Vertex Pharmaceuticals in Q4 2013 and has held it in 6 quarters since.
Guardian Investor Services's Vertex Pharmaceuticals position peaked at $198K in Q4 2014.
480 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2015.

Based on Guardian Investor Services's 13F filing for Q1 2015, filed 5 May 2015.